NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6100
Dollar change
-0.0156
Percentage change
-2.49
%
Index- P/E- EPS (ttm)-1.29 Insider Own20.99% Shs Outstand82.71M Perf Week-3.91%
Market Cap50.45M Forward P/E- EPS next Y-0.89 Insider Trans0.00% Shs Float65.35M Perf Month-15.28%
Enterprise Value-83.74M PEG- EPS next Q-0.30 Inst Own49.04% Short Float4.43% Perf Quarter-26.52%
Income-117.32M P/S- EPS this Y24.19% Inst Trans-3.53% Short Ratio5.37 Perf Half Y-33.42%
Sales0.00M P/B0.31 EPS next Y12.23% ROA-48.44% Short Interest2.89M Perf YTD-36.59%
Book/sh1.95 P/C0.34 EPS next 5Y19.34% ROE-55.83% 52W High1.70 -64.12% Perf Year-54.48%
Cash/sh1.82 P/FCF- EPS past 3/5Y12.69% 36.74% ROIC-67.15% 52W Low0.45 36.43% Perf 3Y-94.93%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.90% 7.82% Perf 5Y-96.24%
Dividend TTM- EV/Sales- EPS Y/Y TTM56.29% Oper. Margin- ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio9.34 Sales Y/Y TTM- Profit Margin- RSI (14)38.93 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio9.34 EPS Q/Q12.56% SMA20-14.75% Beta1.64 Target Price6.00
Payout- Debt/Eq0.10 Sales Q/Q- SMA50-9.35% Rel Volume1.39 Prev Close0.63
Employees152 LT Debt/Eq0.08 EarningsMay 06 AMC SMA200-35.91% Avg Volume538.30K Price0.61
IPOJan 26, 2018 Option/ShortYes / Yes EPS/Sales Surpr.6.54% - Trades Volume750,689 Change-2.49%
Date Action Analyst Rating Change Price Target Change
Sep-30-24Resumed Guggenheim Buy $7
Sep-11-24Downgrade H.C. Wainwright Buy → Neutral
Jun-27-23Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-27-23Downgrade Guggenheim Buy → Neutral
Jun-01-23Downgrade JP Morgan Overweight → Neutral $20 → $6
Sep-21-22Initiated JP Morgan Overweight $23
Mar-31-22Initiated SMBC Nikko Outperform $28
Mar-08-22Initiated Truist Buy $30
Mar-04-22Initiated Jefferies Buy $27
May-18-21Initiated BTIG Research Buy $34
May-21-25 04:00PM
May-09-25 12:00PM
May-06-25 04:01PM
Apr-30-25 04:47PM
07:00AM
04:30PM Loading…
Apr-28-25 04:30PM
Apr-17-25 07:00AM
Mar-31-25 05:12PM
07:00AM
Mar-23-25 08:43AM
Mar-06-25 04:01PM
Mar-03-25 07:00AM
Feb-27-25 08:36AM
07:00AM
Feb-05-25 07:10AM
06:06PM Loading…
Jan-31-25 06:06PM
Jan-29-25 07:00AM
Jan-08-25 04:10PM
Dec-31-24 04:48PM
Dec-19-24 07:00AM
Dec-18-24 07:00AM
Nov-29-24 04:44PM
Nov-18-24 04:00PM
07:00AM
Nov-16-24 09:00AM
Nov-06-24 04:00PM
Nov-05-24 07:00AM
Nov-01-24 07:00AM
Oct-31-24 05:31PM
Oct-17-24 07:27AM
07:00AM Loading…
Oct-16-24 07:00AM
Sep-30-24 05:08PM
04:30PM
07:00AM
Sep-19-24 07:00AM
Aug-30-24 05:44PM
Aug-27-24 04:00PM
Aug-19-24 07:00AM
Aug-13-24 07:00AM
Aug-01-24 04:00PM
Jul-31-24 05:25PM
Jul-25-24 01:24AM
Jul-09-24 09:52AM
07:34AM
Jul-08-24 07:00AM
Jun-28-24 05:00PM
Jun-24-24 07:00AM
Jun-21-24 11:10AM
10:53AM
Jun-10-24 07:22PM
Jun-05-24 07:00AM
May-31-24 05:41PM
May-29-24 07:00AM
May-14-24 09:54PM
04:01PM
10:00AM
May-07-24 07:00AM
Apr-30-24 05:10PM
Apr-22-24 04:30PM
Apr-08-24 07:00AM
Apr-04-24 08:38AM
Apr-01-24 09:40AM
Mar-28-24 05:19PM
Mar-22-24 09:35AM
Mar-19-24 09:53PM
04:10PM
Mar-15-24 09:40AM
Mar-11-24 07:00AM
Feb-29-24 07:46PM
Feb-28-24 09:40AM
Feb-12-24 09:40AM
Feb-05-24 04:01PM
Jan-31-24 04:39PM
Jan-30-24 12:51PM
Jan-25-24 04:01PM
09:40AM
Jan-22-24 11:43PM
04:28PM
Jan-04-24 07:00AM
Jan-03-24 04:01PM
Dec-29-23 04:50PM
Dec-10-23 12:00PM
Nov-08-23 04:10PM
Nov-07-23 07:00AM
Nov-02-23 09:00AM
Oct-31-23 06:25PM
Oct-04-23 12:00PM
Sep-29-23 05:24PM
Sep-27-23 09:00AM
Aug-31-23 04:35PM
Aug-12-23 08:16AM
Aug-09-23 04:15PM
Aug-02-23 04:00PM
Jul-31-23 04:50PM
Jul-11-23 08:30AM
Jun-30-23 04:51PM
Jun-26-23 04:00PM
Jun-01-23 07:00AM
May-31-23 04:53PM
May-18-23 06:00AM
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of "off-the-shelf" gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.